Phase 2 trial of talabostat in stage IV melanoma.

被引：0
作者：
Redman, BG
Ernstoff, MS
Gajewski, TF
Cunningham, C
Lawson, DH
Gregoire, L
Haltom, E
Uprichard, MJ
机构：
[1] Univ Michigan, Comp Canc Ctr, Ann Arbor, MI 48109 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Univ Chicago, Chicago, IL 60637 USA
[4] Mary Crowley Med Res Ctr, Dallas, TX USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Point Therapeut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：727S / 727S
页数：1
相关论文
共 50 条
[41]   Phase II trial evaluating docetaxel and vinorelbine with GM-CSF in stage IV melanoma [J].
Fruehauf, John ;
Jakowatz, James ;
Kong, Kevin ;
Antonio, Sanchez ;
Eroglu, Zeynep .
CANCER RESEARCH, 2009, 69
[42]   Final results of a phase II immunotherapy trial for stage III and IV melanoma patients. [J].
Riker, Adam Irwin ;
Rossi, Gabriela R. ;
Alsfeld, Leonard C. ;
Denham, Fiona ;
Tennant, Lucinda ;
Ramsey, William Jay ;
Link, Charles J. ;
Harrison, Marilynn ;
Vahanian, Nicholas N. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[43]   Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma. [J].
Morton, DL ;
Essner, R ;
Hsueh, EC ;
Wanek, LA ;
Foshag, LJ ;
O'Day, SJ ;
Gupta, RK ;
Hoon, DS ;
Gammon, G .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :173S-173S
[44]   Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma. [J].
Bloom, Jon ;
Donia, Marco ;
Andersen, Rikke ;
Hadrup, Sine Raker ;
Lyngaa, Rikke ;
Svane, Inge Marie .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[45]   Final results of a pilot study using sunitinib malate in patients with stage IV uveal melanoma. [J].
Tijani, L. A. ;
Luadadio, M. ;
Mastrangelo, M. J. ;
Sato, T. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[46]   Effect of denileukin diftitox on serum GM-CSF and clinical responses in stage IV melanoma. [J].
Chesney, J. ;
Rasku, M. A. ;
Klarer, A. C. ;
Miller, D. M. ;
Telang, S. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[47]   A phase 2 trial of high-dose allovectin-7 in patients with advanced metastatic melanoma. [J].
Richards, J ;
Bedikian, AY ;
Gonzalez, R ;
Atkins, MB ;
Whitman, ED ;
Lutzky, J ;
Morse, MA ;
Amatruda, T ;
Galanis, E .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :712S-712S
[48]   A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma. [J].
Shaikh, Saba ;
Zang, Yan ;
Hanmer, Janel ;
Wang, Hong ;
Lin, Yan ;
Davar, Diwakar ;
Zarour, Hassane M. ;
Kirkwood, John M. ;
Najjar, Yana G. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[49]   A phase I, open-label, cohort study of two doses of coxsackievirus A21 given intratumorally in stage IV melanoma. [J].
Shafren, D. ;
Smithers, B. M. ;
Formby, M. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[50]   A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma. [J].
Mehnert, Janice M. ;
Semlani, Neha ;
Wen, Yvonne ;
Tan, Antoinette R. ;
Moss, Rebecca Anne ;
Adams, Shari ;
Stein, Mark N. ;
Ross, Mikel ;
Kane, Michael P. ;
Gibbon, Darlene ;
Wright, John Joseph ;
Aisner, Joseph ;
Chen, Suzie ;
Goydos, James S. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345